Premium
Aliskiren alone or in combination with enalapril vs. enalapril among patients with chronic heart failure with and without diabetes: a subgroup analysis from the ATMOSPHERE trial
Author(s) -
Kristensen Søren L.,
Mogensen Ulrik M.,
Tarnesby Georgia,
Gimpelewicz Claudio R.,
Ali Mohammed A.,
Shao Qing,
Chiang YannTong,
Jhund Pardeep S.,
Abraham William T.,
Dickstein Kenneth,
McMurray John J.V.,
Køber Lars
Publication year - 2018
Publication title -
european journal of heart failure
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.149
H-Index - 133
eISSN - 1879-0844
pISSN - 1388-9842
DOI - 10.1002/ejhf.896
Subject(s) - aliskiren , medicine , enalapril , hazard ratio , heart failure , diabetes mellitus , clinical endpoint , cardiology , type 2 diabetes , ejection fraction , confidence interval , randomized controlled trial , endocrinology , angiotensin converting enzyme , renin–angiotensin system , blood pressure